Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/192884
Cellular senescence is immunogenic and promotes anti-tumor immunity
Journal Title
Director/Tutor
Additional contribution
Journal ISSN
Volume Title
Abstract
Cellular senescence is a stress response that activates innate immune cells, but little is known about its interplay with the adaptive immune system. Here, we show that senescent cells combine several features that render them highly efficient in activating dendritic cells (DCs) and antigen-specific CD8 T cells. This includes the release of alarmins, activation of interferon signaling, enhanced MHC class I machinery, and presentation of senescence-specific self-peptides that can activate CD8 T cells. In the context of cancer, immunization with senescent cancer cells elicits strong anti-tumor protection mediated by DCs and CD8 T cells. Interestingly, this protection is superior to immunization with cancer cells undergoing immunogenic cell death. Finally, the induction of senescence in human primary cancer cells also augments their ability to activate autologous antigen-specific tumor-infiltrating CD8 lymphocytes. Our study indicates that senescent cancer cells can be exploited to develop efficient and protective CD8-dependent anti-tumor immune responses.
Related resource
Subject (English)
Citation
Citation
MARIN, Ines, et al. Cellular senescence is immunogenic and promotes anti-tumor immunity. Cancer Discovery. 2023. Vol. 13, num. 2, pags. 410-431. ISSN 2159-8290. [consulted: 17 of October of 2026]. Available at: https://hdl.handle.net/2445/192884